[5] Most people adapt well to this change, though some experience altered fat digestion, particularly immediately after eating fatty foods
That is a mean difference of 9.1 fewer headache days per month, a reduction that reached statistical significance with a p-value less than 0.001
Also available in the UAE and Oman through official partners
J., & Baur, L
Among type 2 diabetic patients with or without AD who were treated with GLP-1RAs, no differences were seen in the risks for mortality, new-onset MACE, MI, heart failure, or stroke
Beyond T2D and obesity, semaglutide was also applied for other indications such as cardiovascular disease, fatty liver, chronic kidney disease, all of which have progressed to Phase 3, expanding the influence of GLP-1RAs into more medical fields